文献速递肝胆胰外科胃肠外科围术期管理与 ERAS

ALPPS治疗晚期结直肠癌肝转移的中期生存与生活质量结局

Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy.
PubMed 文献 · Surgery · 2017-12-06

该研究联合两家高容量ALPPS中心的前瞻性数据,纳入47例初始不可切除、接受术前化疗的结直肠癌肝转移患者,评估ALPPS术后无病生存、总生存及生活质量。结果显示无围手术期死亡,严重并发症率21%,术后3年总生存50%、无病生存13%,最常见首发复发部位为单纯肝脏(38%),患者报告生活质量与一般人群参考值相似。

要点

  • ALPPS术后3年总生存50%、无病生存13%,无围手术期死亡。
  • 严重并发症率21%,最常见首发复发为单纯肝脏(38%)。
  • 患者报告生活质量与一般人群参考值相似。

核心结论

  • 在经验丰富的中心选择合适患者,ALPPS围手术期风险低、总生存满意且生活质量优良。
  • ALPPS术后最常见复发部位为肝脏而非全身性复发。

研究设计与样本

  • 联合两家高容量ALPPS中心的前瞻性数据,分析无病生存与总生存。
  • 纳入47例结直肠癌肝转移患者,均为双侧肝转移、初始不可切除并接受术前化疗,术后随访>6个月。

主要发现

  • 58例患者接受ALPPS,47例符合纳入标准。
  • 无围手术期死亡,严重并发症率为21%。
  • 术后3年总生存为50%,无病生存为13%。
  • 最常见首发复发部位为单纯肝脏(38%)。
  • 患者报告的生活质量与一般人群参考值相似。

临床怎么用

  • 对于初始不可切除的结直肠癌肝转移,可在经验丰富中心选择合适患者行ALPPS。
  • 术后随访应重点关注肝脏复发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is an innovative, 2-staged hepatectomy which has elicited controversy within the international hepatobiliary community. Uptake of ALPPS has been limited due to concerns related to evidence of high morbidity and mortality, and scant oncologic and outcome data on quality of life (Qol). Demonstrating reasonable long-term benefits with a short-term risk is necessary to support more widespread endorsement of ALPPS. Our aim was to describe the intermediate-term survival and patient-reported quality of life outcomes after an ALPPS. METHODS: Prospectively collected data from 2 high-volume ALPPS centers, who were pioneers with the technique, were combined and analyzed for disease-free and overall survival from date of the ALLPS. Only patients treated for colorectal liver metastases with >6 month postoperative follow-up were included. All patients had bilateral colorectal liver metastases with an initially unresectable tumor load, and received preoperative chemotherapy. Information concerning the demographics of the patients, characteristics of the tumor, and treatment were analyzed. The well-validated European Organization for Research and Treatment for Cancer Quality of Life Core Questionnaire version 3.0 questionnaire was used to assess patient quality of life. RESULTS: A total of 58 patients underwent ALPPS for colorectal liver metastases, and 47 patients met our inclusion criteria. There were no perioperative mortalities, and the rate of severe complications was 21%. At 3 years post-ALPPS, the overall survival was 50%, while the disease-free survival was 13%. The commonest site of first recurrence was the liver alone (38%). Patient-reported quality of life after ALPPS was similar to reference values for general population. CONCLUSION: In select patients operated at experienced centers, ALPPS results in low perioperative risk, satisfactory overall survival, and excellent quality of life. Hepatic recurrence and not systemic recurrence is the most common site of relapse after ALPPS.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Wanis KN, Ardiles V, Alvarez FA, et al. Intermediate-term survival and quality of life outcomes in patients with advanced colorectal liver metastases undergoing associating liver partition and portal vein ligation for staged hepatectomy. Surgery. 2017. PMID: 29203284. doi:10.1016/j.surg.2017.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。